APA (7th ed.) Citation

Mason, J. B., Azari, S., Kenigsberg, A. P., Blake, Z., Nemirovsky, D. R., Koller, C., . . . Mezhiritsky, V. (2024). FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT. Urologic Oncology, 42, S93. https://doi.org/10.1016/j.urolonc.2024.01.260

Chicago Style (17th ed.) Citation

Mason, J. Bradley, et al. "FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT." Urologic Oncology 42 (2024): S93. https://doi.org/10.1016/j.urolonc.2024.01.260.

MLA (9th ed.) Citation

Mason, J. Bradley, et al. "FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT." Urologic Oncology, vol. 42, 2024, p. S93, https://doi.org/10.1016/j.urolonc.2024.01.260.